Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
1 other identifier
observational
100
1 country
1
Brief Summary
AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 24, 2010
CompletedFirst Posted
Study publicly available on registry
November 29, 2010
CompletedNovember 29, 2010
September 1, 2010
November 24, 2010
November 26, 2010
Conditions
Keywords
Eligibility Criteria
Lung cancer received lobectomy in CMUH
You may qualify if:
- Lung cancer received operation lobectomy in CMUH
You may not qualify if:
- History of uremia, other malignant disease, and liver cirrhosis
- History of pneumonia and pulmonary tuberculosis
- History of long period of medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fang Hsin Yuan
Taichung, 404, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 24, 2010
First Posted
November 29, 2010
Study Start
September 1, 2010
Last Updated
November 29, 2010
Record last verified: 2010-09